Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ventripoint Diagnostics Ltd (OP: VPTDF ) 0.1034 +0.0030 (+2.99%) Streaming Delayed Price Updated: 2:50 PM EST, Nov 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ventripoint Diagnostics Ltd Ventripoint's Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification October 11, 2024 Toronto, Ontario - TheNewswire - (October 11, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce that it has submitted its next... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User August 22, 2023 Toronto, Ontario – TheNewswire – August 22, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Evelina London Children’s Hospital... Via TheNewswire.com Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options April 01, 2022 Toronto, Ontario – TheNewswire – April 1, 2022 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that it will be exhibiting at the 71st... Via TheNewswire.com Ventripoint Announces Patent Application for Improved Heart Analysis August 09, 2021 Toronto, Ontario – TheNewswire – August 09, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has filed an international patent application under the Patent... Via TheNewswire.com Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Ventripoint Engages Digital257 for Social Media and Investor Relations Services July 05, 2021 Toronto, Ontario – TheNewswire – July 5, 2021 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ; (OTC:VPTDF) is pleased to announce that it has engaged Digital257... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence Ventripoint Issues Option Grants to Consultants and a Director of the Corporation July 02, 2021 Toronto, Ontario – TheNewswire – July 2, 2021 - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) (TSXV:VPT) (OTC:VPTDF) announces that on July 1, 2021 the Board of Directors... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology May 21, 2021 Ventripoint Also Provides a Financial Update Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence Ventripoint update on its Financial Status and on Warrant and Option Exercises May 06, 2021 Toronto, Ontario – TheNewswire – May 6, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to provide this update on its financial status and the... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence COVID-19 Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+ May 04, 2021 Toronto, Ontario – TheNewswire – May 4, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is excited to announce that it is receiving advisory services and... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence COVID-19 Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices April 27, 2021 Toronto, Ontario - The Newswire - April 27, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) announces the Company has entered into a collaboration with GE... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options April 20, 2021 Toronto, Ontario – TheNewswire – April 20, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) attended the 23rd Annual Canadian Echo Weekend – 2021 Digital... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology April 19, 2021 Toronto, Ontario - The Newswire - April 19, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) has filed a U.S. provisional patent application for its novel... Via TheNewswire.com Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence COVID-19 Intellectual Property Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference April 15, 2021 Toronto, Ontario – TheNewswire – April 15, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce its sponsorship of the 2021 Canadian... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System April 13, 2021 Toronto, Ontario – TheNewswire – April 13, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has published its first case study of the meritorious use of the... Via TheNewswire.com Topics Artificial Intelligence Exposures Artificial Intelligence COVID-19 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
